BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/03/2000

Sankyo Co., Ltd.; Withdrawal of GRAS Affirmation Petition

The Food and Drug Administration (FDA) is announcing the withdrawal, without prejudice to a future filing, of a petition (GRASP 6G0420) proposing to affirm that the use of dextranase enzyme preparation derived from Chaetomium gracile is generally recognized as safe (GRAS) in cane and beet sugar processing.

Source: Federal Register — Food and Drug AdministrationOpen original release →